Literature DB >> 6198380

Localized conformational changes induced in a class I major histocompatibility antigen by the binding of monoclonal antibodies.

A G Diamond, G W Butcher, J C Howard.   

Abstract

We describe two monoclonal antibodies, R3/47 and YR1/1, directed against different epitopes of the expressed rat class I major transplantation antigen RT1Aa, that interact with each other so that the binding of one antibody, YR1/1, is greatly enhanced by the binding of the other. The positive interaction between R3/47 and YR1/1 also occurs when using RT1Aa molecules solubilized from cell membranes in detergent. It is therefore unlikely that the molecular environment of the membrane contributes to the interaction. The ability of R3/47 to modify the YR1/1 determinant on the RT1Aa molecule is mediated without any significant loss of potency by highly purified monomeric Fab fragments. This result suggests that the binding of R3/47 to the RT1Aa molecule alters the YR1/1 determinant by initiating a propagated conformational change in the antigen.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6198380

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Allosteric effects of monoclonal antibodies on human growth hormone.

Authors:  R C Aguilar; L A Retegui; M C Postel-Vinay; L P Roguin
Journal:  Mol Cell Biochem       Date:  1994-07-13       Impact factor: 3.396

2.  Stochastic humoral expression of human growth hormone epitopes.

Authors:  M Etcheverrigaray; A C Paladini; L A Retegui
Journal:  Immunology       Date:  1988-04       Impact factor: 7.397

3.  Monoclonal antibodies to human growth hormone induce an allosteric conformational change in the antigen.

Authors:  M M Mazza; L A Retegui
Journal:  Immunology       Date:  1989-06       Impact factor: 7.397

4.  Collaborative enhancement of antibody binding to distinct PECAM-1 epitopes modulates endothelial targeting.

Authors:  Ann-Marie Chacko; Madhura Nayak; Colin F Greineder; Horace M Delisser; Vladimir R Muzykantov
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.